Cuba vs Europe (WHO region): Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Cuba
99.0%
in 2025
Europe (WHO region)
89.0%
in 2025
Cuba rank
1st
Europe (WHO region) rank
2nd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Cuba
- Europe (WHO region)
How they compare
Cuba currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Cuba's figure about 1.1 times Europe (WHO region)'s.
Across all 5 years both countries report, Cuba has been ahead every year.
Cuba ranks 1st and Europe (WHO region) ranks 2nd of 194 countries.
Cuba has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Cuba or Europe (WHO region)?
- Cuba, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Cuba and Europe (WHO region)?
- 10.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Europe (WHO region)?
- 5 years are reported by both, from 2021 to 2025.
- How do Cuba and Europe (WHO region) rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Cuba ranks 1st and Europe (WHO region) ranks 2nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.